Aandeel THER THERALINK TECHNOLOGIES, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Theralink Technologies, Inc.

Aandelen

THER

US88339Q1094

Beurs gesloten - OTC Markets
Andere beurzen
 18:28:55 05-06-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,0001 USD 0,00% Intraday-grafiek van Theralink Technologies, Inc. 0,00% -93,33%
07/05 IMAC Holdings, Inc. (NasdaqCM:BACK) heeft de activa van Theralink Technologies, Inc. overgenomen. CI
06/05 Theralink Technologies, Inc. (OTCPK:THER) heeft de overname van IMAC Holdings, Inc. (NasdaqCM:BACK) in een omgekeerde fusie transactie geannuleerd. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
IMAC Holdings, Inc. acquired Assets of Theralink Technologies, Inc.
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.
Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors
Theralink Technologies, Inc. Announces Chief Executive Officer Changes
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary
Theralink Technologies, Inc. Announces CFO Changes
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers THER
  4. Nieuws Theralink Technologies, Inc.
  5. Andere talen